Anling Biopharmaceutical (Suzhou) Co., Ltd. was established in May 2017. In July 2018, the initial team of Anling was formed and officially began providing services. In September 2021, the company passed the official NMPA certification and obtained the NMPA GLP qualification. It is a professional contract research organization (CRO) initiated and established by the Drug Safety and Evaluation Research Center of the Shanghai Institute of Materia Medica, Chinese Academy of Sciences. The company mainly focuses on preclinical R&D technical services, including preclinical research on small-molecule chemical drugs, large-molecule biological drugs, traditional Chinese medicines, and cell therapy products, covering pharmacological and pharmacodynamic studies, drug metabolism studies, drug safety evaluation, and clinical biological sample analysis. The company's main clients are new drug R&D companies, generic drug manufacturers, and chemical R&D and manufacturing companies. It provides preclinical research technical services in the fields of chemical drugs, biological drugs, traditional Chinese medicines, medical devices, cell therapy products, and chemicals.
What does Anling Biopharmaceutical (Suzhou) Co., Ltd. require? Who is Suzhou Anling Biopharmaceutical hiring? Suzhou Anling Biopharmaceutical recruitment: Factory Production占比最多占54.2%,其次是Medical & Health/Beauty & Healthcare占41.7%. What education can get in at Suzhou Anling Biopharmaceutical? 不限占比最多占37.5%,其次是大专占25%. High education required at Suzhou Anling Biopharmaceutical? 硕士占12.5%. Work experience required at Suzhou Anling Biopharmaceutical? 不限占比最多占75%,其次是1-3年占16.7%. Where are the job locations at Suzhou Anling Biopharmaceutical? 苏州占比最多占62.5%,其次是深圳占37.5%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows